Bilateral Urethral Stents Are NOT a Contraindication for TMS
Bilateral urethral stents do not contraindicate transcranial magnetic stimulation (TMS) because the magnetic field is applied to the head/brain, and urethral stents are located far from the stimulation site in the pelvis, making any interaction with the magnetic field negligible.
Key Safety Considerations for TMS and Implants
The primary safety concern with TMS relates to metallic implants near the stimulation site (the head and brain), not distant body locations 1. The established TMS safety guidelines focus on:
- Minimizing seizure risk as the primary safety concern
- Presence of implants in or near the skull as a relevant contraindication
- Skull defects near the stimulation area
Evidence on Stents and TMS Safety
Research has specifically examined stents in relation to TMS, though focused on vascular stents near the brain:
- Carotid artery stents showed no migration, temperature elevation, or thermal injury when exposed to prolonged continuous theta burst stimulation at high intensity 2
- Nitinol and elgiloy stents (commonly used in stroke patients) heated less than 1°C with both 1 Hz and 10 Hz rTMS protocols—well below FDA safety standards of 2°C 3
Why Urethral Stents Are Not Relevant
The magnetic field strength from TMS decreases exponentially with distance from the coil. Since:
- TMS coils are applied directly to the scalp
- The magnetic field penetrates only a few centimeters into brain tissue
- Urethral stents are located in the pelvis, approximately 1-2 meters from the stimulation site
There is no plausible mechanism for clinically significant interaction between the TMS magnetic field and urethral stents.
Standard TMS Contraindications to Actually Consider
Focus instead on established contraindications 1:
- Metallic implants in the head (cochlear implants, deep brain stimulators, aneurysm clips)
- Skull defects or fractures
- Factors increasing seizure risk (recent cocaine use, alcohol withdrawal, certain medications like bupropion or tramadol)
- Cardiac pacemakers or implanted defibrillators (though even these are primarily concerning if near the magnetic field)
Proceed with TMS in patients with bilateral urethral stents without additional precautions beyond standard TMS safety protocols.